Epithelial-Mesenchymal Transition, human (Scheel, 2011)
Name | miRBASE accession |
---|---|
hsa-miR-15a-5p
|
MIMAT0000068 |
hsa-miR-15b-5p
|
MIMAT0000417 |
hsa-miR-16-5p
|
MIMAT0000069 |
hsa-miR-195-5p
|
MIMAT0000461 |
hsa-miR-424-5p
|
MIMAT0001341 |
hsa-miR-497-5p
|
MIMAT0002820 |
hsa-miR-6838-5p
|
MIMAT0027578 |
Promoter | Score | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr5_+_167181917 | 2.51 |
ENST00000519204.1 |
TENM2 |
teneurin transmembrane protein 2 |
chr9_-_27529726 | 2.49 |
ENST00000262244.5 |
MOB3B |
MOB kinase activator 3B |
chr6_-_136871957 | 2.33 |
ENST00000354570.3 |
MAP7 |
microtubule-associated protein 7 |
chr8_+_95653373 | 2.25 |
ENST00000358397.5 |
ESRP1 |
epithelial splicing regulatory protein 1 |
chr2_-_46385 | 2.14 |
ENST00000327669.4 |
FAM110C |
family with sequence similarity 110, member C |
chr12_+_4382917 | 1.93 |
ENST00000261254.3 |
CCND2 |
cyclin D2 |
chr5_+_140220769 | 1.68 |
ENST00000531613.1 ENST00000378123.3 |
PCDHA8 |
protocadherin alpha 8 |
chr5_+_140227048 | 1.67 |
ENST00000532602.1 |
PCDHA9 |
protocadherin alpha 9 |
chr5_+_140213815 | 1.67 |
ENST00000525929.1 ENST00000378125.3 |
PCDHA7 |
protocadherin alpha 7 |
chr5_+_140254884 | 1.66 |
ENST00000398631.2 |
PCDHA12 |
protocadherin alpha 12 |
chr5_+_140248518 | 1.62 |
ENST00000398640.2 |
PCDHA11 |
protocadherin alpha 11 |
chr16_-_68269971 | 1.55 |
ENST00000565858.1 |
ESRP2 |
epithelial splicing regulatory protein 2 |
chr2_-_122042770 | 1.54 |
ENST00000263707.5 |
TFCP2L1 |
transcription factor CP2-like 1 |
chr3_-_13921594 | 1.50 |
ENST00000285018.4 |
WNT7A |
wingless-type MMTV integration site family, member 7A |
chr4_+_77356248 | 1.47 |
ENST00000296043.6 |
SHROOM3 |
shroom family member 3 |
chr7_-_143105941 | 1.37 |
ENST00000275815.3 |
EPHA1 |
EPH receptor A1 |
chr7_-_83824169 | 1.33 |
ENST00000265362.4 |
SEMA3A |
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3A |
chr5_+_167718604 | 1.25 |
ENST00000265293.4 |
WWC1 |
WW and C2 domain containing 1 |
chr1_+_209848749 | 1.23 |
ENST00000367029.4 |
G0S2 |
G0/G1switch 2 |
chr10_+_95653687 | 1.21 |
ENST00000371408.3 ENST00000427197.1 |
SLC35G1 |
solute carrier family 35, member G1 |
chr17_-_56494713 | 1.14 |
ENST00000407977.2 |
RNF43 |
ring finger protein 43 |
chr11_-_119599794 | 1.13 |
ENST00000264025.3 |
PVRL1 |
poliovirus receptor-related 1 (herpesvirus entry mediator C) |
chr1_+_65613217 | 1.10 |
ENST00000545314.1 |
AK4 |
adenylate kinase 4 |
chr5_+_140345820 | 1.07 |
ENST00000289269.5 |
PCDHAC2 |
protocadherin alpha subfamily C, 2 |
chr11_-_115375107 | 1.07 |
ENST00000545380.1 ENST00000452722.3 ENST00000537058.1 ENST00000536727.1 ENST00000542447.2 ENST00000331581.6 |
CADM1 |
cell adhesion molecule 1 |
chr6_-_97285336 | 1.04 |
ENST00000229955.3 ENST00000417980.1 |
GPR63 |
G protein-coupled receptor 63 |
chr8_+_61591337 | 1.02 |
ENST00000423902.2 |
CHD7 |
chromodomain helicase DNA binding protein 7 |
chr8_-_75233563 | 1.01 |
ENST00000342232.4 |
JPH1 |
junctophilin 1 |
chr11_+_72929319 | 1.00 |
ENST00000393597.2 ENST00000311131.2 |
P2RY2 |
purinergic receptor P2Y, G-protein coupled, 2 |
chr6_-_170599561 | 0.99 |
ENST00000366756.3 |
DLL1 |
delta-like 1 (Drosophila) |
chr5_+_140207536 | 0.97 |
ENST00000529310.1 ENST00000527624.1 |
PCDHA6 |
protocadherin alpha 6 |
chr14_+_67999999 | 0.96 |
ENST00000329153.5 |
PLEKHH1 |
pleckstrin homology domain containing, family H (with MyTH4 domain) member 1 |
chr9_-_140196703 | 0.96 |
ENST00000356628.2 |
NRARP |
NOTCH-regulated ankyrin repeat protein |
chr14_-_99737565 | 0.94 |
ENST00000357195.3 |
BCL11B |
B-cell CLL/lymphoma 11B (zinc finger protein) |
chr17_+_30813576 | 0.93 |
ENST00000313401.3 |
CDK5R1 |
cyclin-dependent kinase 5, regulatory subunit 1 (p35) |
chr19_+_45281118 | 0.93 |
ENST00000270279.3 ENST00000341505.4 |
CBLC |
Cbl proto-oncogene C, E3 ubiquitin protein ligase |
chr6_+_43737939 | 0.92 |
ENST00000372067.3 |
VEGFA |
vascular endothelial growth factor A |
chr5_+_140306478 | 0.92 |
ENST00000253807.2 |
PCDHAC1 |
protocadherin alpha subfamily C, 1 |
chr8_-_42397037 | 0.91 |
ENST00000342228.3 |
SLC20A2 |
solute carrier family 20 (phosphate transporter), member 2 |
chr16_+_57406368 | 0.91 |
ENST00000006053.6 ENST00000563383.1 |
CX3CL1 |
chemokine (C-X3-C motif) ligand 1 |
chr18_+_29598335 | 0.88 |
ENST00000217740.3 |
RNF125 |
ring finger protein 125, E3 ubiquitin protein ligase |
chr1_-_48462566 | 0.87 |
ENST00000606738.2 |
TRABD2B |
TraB domain containing 2B |
chr1_-_41131326 | 0.84 |
ENST00000372684.3 |
RIMS3 |
regulating synaptic membrane exocytosis 3 |
chr12_-_28124903 | 0.83 |
ENST00000395872.1 ENST00000354417.3 ENST00000201015.4 |
PTHLH |
parathyroid hormone-like hormone |
chr5_+_140261703 | 0.82 |
ENST00000409494.1 ENST00000289272.2 |
PCDHA13 |
protocadherin alpha 13 |
chr5_+_140165876 | 0.82 |
ENST00000504120.2 ENST00000394633.3 ENST00000378133.3 |
PCDHA1 |
protocadherin alpha 1 |
chr5_+_140180635 | 0.82 |
ENST00000522353.2 ENST00000532566.2 |
PCDHA3 |
protocadherin alpha 3 |
chr12_-_31479045 | 0.81 |
ENST00000539409.1 ENST00000395766.1 |
FAM60A |
family with sequence similarity 60, member A |
chr11_-_118023490 | 0.80 |
ENST00000324727.4 |
SCN4B |
sodium channel, voltage-gated, type IV, beta subunit |
chr6_+_37137939 | 0.79 |
ENST00000373509.5 |
PIM1 |
pim-1 oncogene |
chr2_-_72375167 | 0.78 |
ENST00000001146.2 |
CYP26B1 |
cytochrome P450, family 26, subfamily B, polypeptide 1 |
chr2_+_26568965 | 0.78 |
ENST00000260585.7 ENST00000447170.1 |
EPT1 |
ethanolaminephosphotransferase 1 (CDP-ethanolamine-specific) |
chr13_-_86373536 | 0.77 |
ENST00000400286.2 |
SLITRK6 |
SLIT and NTRK-like family, member 6 |
chr1_-_156786530 | 0.77 |
ENST00000368198.3 |
SH2D2A |
SH2 domain containing 2A |
chr4_+_20255123 | 0.76 |
ENST00000504154.1 ENST00000273739.5 |
SLIT2 |
slit homolog 2 (Drosophila) |
chr7_-_20256965 | 0.75 |
ENST00000400331.5 ENST00000332878.4 |
MACC1 |
metastasis associated in colon cancer 1 |
chr1_+_233463507 | 0.75 |
ENST00000366623.3 ENST00000366624.3 |
MLK4 |
Mitogen-activated protein kinase kinase kinase MLK4 |
chr17_+_35294075 | 0.72 |
ENST00000254457.5 |
LHX1 |
LIM homeobox 1 |
chr9_-_126030817 | 0.71 |
ENST00000348403.5 ENST00000447404.2 ENST00000360998.3 |
STRBP |
spermatid perinuclear RNA binding protein |
chr12_-_26278030 | 0.71 |
ENST00000242728.4 |
BHLHE41 |
basic helix-loop-helix family, member e41 |
chr3_-_48229846 | 0.70 |
ENST00000302506.3 ENST00000351231.3 ENST00000437972.1 |
CDC25A |
cell division cycle 25A |
chr3_-_129407535 | 0.67 |
ENST00000432054.2 |
TMCC1 |
transmembrane and coiled-coil domain family 1 |
chr4_-_25864581 | 0.65 |
ENST00000399878.3 |
SEL1L3 |
sel-1 suppressor of lin-12-like 3 (C. elegans) |
chr1_-_9970227 | 0.64 |
ENST00000377263.1 |
CTNNBIP1 |
catenin, beta interacting protein 1 |
chr1_+_82266053 | 0.63 |
ENST00000370715.1 ENST00000370713.1 ENST00000319517.6 ENST00000370717.2 ENST00000394879.1 ENST00000271029.4 ENST00000335786.5 |
LPHN2 |
latrophilin 2 |
chr5_+_140235469 | 0.63 |
ENST00000506939.2 ENST00000307360.5 |
PCDHA10 |
protocadherin alpha 10 |
chr2_+_148602058 | 0.62 |
ENST00000241416.7 ENST00000535787.1 ENST00000404590.1 |
ACVR2A |
activin A receptor, type IIA |
chr6_+_71122974 | 0.61 |
ENST00000418814.2 |
FAM135A |
family with sequence similarity 135, member A |
chr2_+_206547215 | 0.60 |
ENST00000360409.3 ENST00000540178.1 ENST00000540841.1 ENST00000355117.4 ENST00000450507.1 ENST00000417189.1 |
NRP2 |
neuropilin 2 |
chr20_+_49348081 | 0.59 |
ENST00000371610.2 |
PARD6B |
par-6 family cell polarity regulator beta |
chr6_+_15246501 | 0.59 |
ENST00000341776.2 |
JARID2 |
jumonji, AT rich interactive domain 2 |
chr20_+_35201857 | 0.59 |
ENST00000373874.2 |
TGIF2 |
TGFB-induced factor homeobox 2 |
chr1_+_224803995 | 0.58 |
ENST00000272133.3 |
CNIH3 |
cornichon family AMPA receptor auxiliary protein 3 |
chr9_+_470288 | 0.58 |
ENST00000382303.1 |
KANK1 |
KN motif and ankyrin repeat domains 1 |
chr7_-_138666053 | 0.57 |
ENST00000440172.1 ENST00000422774.1 |
KIAA1549 |
KIAA1549 |
chr6_+_135502466 | 0.56 |
ENST00000367814.4 |
MYB |
v-myb avian myeloblastosis viral oncogene homolog |
chr2_-_208030647 | 0.56 |
ENST00000309446.6 |
KLF7 |
Kruppel-like factor 7 (ubiquitous) |
chr12_-_8088871 | 0.55 |
ENST00000075120.7 |
SLC2A3 |
solute carrier family 2 (facilitated glucose transporter), member 3 |
chr5_+_140186647 | 0.55 |
ENST00000512229.2 ENST00000356878.4 ENST00000530339.1 |
PCDHA4 |
protocadherin alpha 4 |
chr6_+_80341000 | 0.55 |
ENST00000369838.4 |
SH3BGRL2 |
SH3 domain binding glutamic acid-rich protein like 2 |
chr2_+_112812778 | 0.54 |
ENST00000283206.4 |
TMEM87B |
transmembrane protein 87B |
chr5_+_52285144 | 0.53 |
ENST00000296585.5 |
ITGA2 |
integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor) |
chr16_+_81348528 | 0.53 |
ENST00000568107.2 |
GAN |
gigaxonin |
chr6_+_17281573 | 0.51 |
ENST00000379052.5 |
RBM24 |
RNA binding motif protein 24 |
chr1_-_201438282 | 0.51 |
ENST00000367311.3 ENST00000367309.1 |
PHLDA3 |
pleckstrin homology-like domain, family A, member 3 |
chr14_+_70078303 | 0.50 |
ENST00000342745.4 |
KIAA0247 |
KIAA0247 |
chr15_+_66679155 | 0.50 |
ENST00000307102.5 |
MAP2K1 |
mitogen-activated protein kinase kinase 1 |
chr2_-_165697920 | 0.49 |
ENST00000342193.4 ENST00000375458.2 |
COBLL1 |
cordon-bleu WH2 repeat protein-like 1 |
chr7_+_90032667 | 0.49 |
ENST00000496677.1 ENST00000287916.4 ENST00000535571.1 ENST00000394604.1 ENST00000394605.2 |
CLDN12 |
claudin 12 |
chr1_-_217262969 | 0.49 |
ENST00000361525.3 |
ESRRG |
estrogen-related receptor gamma |
chr3_-_123603137 | 0.48 |
ENST00000360304.3 ENST00000359169.1 ENST00000346322.5 ENST00000360772.3 |
MYLK |
myosin light chain kinase |
chrX_+_21392873 | 0.48 |
ENST00000379510.3 |
CNKSR2 |
connector enhancer of kinase suppressor of Ras 2 |
chr4_-_76944621 | 0.47 |
ENST00000306602.1 |
CXCL10 |
chemokine (C-X-C motif) ligand 10 |
chr7_-_994302 | 0.47 |
ENST00000265846.5 |
ADAP1 |
ArfGAP with dual PH domains 1 |
chr13_-_41240717 | 0.47 |
ENST00000379561.5 |
FOXO1 |
forkhead box O1 |
chr4_+_128703295 | 0.45 |
ENST00000296464.4 ENST00000508549.1 |
HSPA4L |
heat shock 70kDa protein 4-like |
chr7_-_98741642 | 0.45 |
ENST00000361368.2 |
SMURF1 |
SMAD specific E3 ubiquitin protein ligase 1 |
chrX_-_30885319 | 0.45 |
ENST00000378933.1 |
TAB3 |
TGF-beta activated kinase 1/MAP3K7 binding protein 3 |
chr12_-_8025442 | 0.44 |
ENST00000340749.5 ENST00000535295.1 ENST00000539234.1 |
SLC2A14 |
solute carrier family 2 (facilitated glucose transporter), member 14 |
chr7_+_30323923 | 0.44 |
ENST00000323037.4 |
ZNRF2 |
zinc and ring finger 2 |
chr3_+_140770183 | 0.43 |
ENST00000310546.2 |
SPSB4 |
splA/ryanodine receptor domain and SOCS box containing 4 |
chr5_+_148206156 | 0.43 |
ENST00000305988.4 |
ADRB2 |
adrenoceptor beta 2, surface |
chr6_+_18387570 | 0.43 |
ENST00000259939.3 |
RNF144B |
ring finger protein 144B |
chr13_-_21476900 | 0.43 |
ENST00000400602.2 ENST00000255305.6 |
XPO4 |
exportin 4 |
chr1_-_47069955 | 0.42 |
ENST00000341183.5 ENST00000496619.1 |
MKNK1 |
MAP kinase interacting serine/threonine kinase 1 |
chr6_+_7107999 | 0.41 |
ENST00000491191.1 ENST00000379938.2 ENST00000471433.1 |
RREB1 |
ras responsive element binding protein 1 |
chr3_-_48471454 | 0.41 |
ENST00000296440.6 ENST00000448774.2 |
PLXNB1 |
plexin B1 |
chr12_-_39837192 | 0.41 |
ENST00000361961.3 ENST00000395670.3 |
KIF21A |
kinesin family member 21A |
chr3_-_171178157 | 0.39 |
ENST00000465393.1 ENST00000436636.2 ENST00000369326.5 ENST00000538048.1 ENST00000341852.6 |
TNIK |
TRAF2 and NCK interacting kinase |
chr2_+_110371905 | 0.38 |
ENST00000356454.3 |
SOWAHC |
sosondowah ankyrin repeat domain family member C |
chr14_-_100070363 | 0.38 |
ENST00000380243.4 |
CCDC85C |
coiled-coil domain containing 85C |
chr7_-_92463210 | 0.38 |
ENST00000265734.4 |
CDK6 |
cyclin-dependent kinase 6 |
chr10_+_101419187 | 0.38 |
ENST00000370489.4 |
ENTPD7 |
ectonucleoside triphosphate diphosphohydrolase 7 |
chr11_-_89956461 | 0.38 |
ENST00000320585.6 |
CHORDC1 |
cysteine and histidine-rich domain (CHORD) containing 1 |
chr7_-_82073109 | 0.37 |
ENST00000356860.3 |
CACNA2D1 |
calcium channel, voltage-dependent, alpha 2/delta subunit 1 |
chr12_-_53473136 | 0.37 |
ENST00000547837.1 ENST00000301463.4 |
SPRYD3 |
SPRY domain containing 3 |
chr6_-_91006461 | 0.37 |
ENST00000257749.4 ENST00000343122.3 ENST00000406998.2 ENST00000453877.1 |
BACH2 |
BTB and CNC homology 1, basic leucine zipper transcription factor 2 |
chr20_-_50419055 | 0.37 |
ENST00000217086.4 |
SALL4 |
spalt-like transcription factor 4 |
chr17_+_4736627 | 0.36 |
ENST00000355280.6 ENST00000347992.7 |
MINK1 |
misshapen-like kinase 1 |
chrX_-_128788914 | 0.35 |
ENST00000429967.1 ENST00000307484.6 |
APLN |
apelin |
chr4_-_153601136 | 0.35 |
ENST00000504064.1 ENST00000304385.3 |
TMEM154 |
transmembrane protein 154 |
chr22_+_29279552 | 0.35 |
ENST00000544604.2 |
ZNRF3 |
zinc and ring finger 3 |
chr9_+_131843377 | 0.35 |
ENST00000372546.4 ENST00000406974.3 ENST00000540102.1 |
DOLPP1 |
dolichyldiphosphatase 1 |
chrX_+_16804544 | 0.34 |
ENST00000380122.5 ENST00000398155.4 |
TXLNG |
taxilin gamma |
chr11_+_73087309 | 0.34 |
ENST00000064780.2 ENST00000545687.1 |
RELT |
RELT tumor necrosis factor receptor |
chr7_+_4721885 | 0.34 |
ENST00000328914.4 |
FOXK1 |
forkhead box K1 |
chr4_-_153457197 | 0.34 |
ENST00000281708.4 |
FBXW7 |
F-box and WD repeat domain containing 7, E3 ubiquitin protein ligase |
chr15_+_98503922 | 0.34 |
ENST00000268042.6 |
ARRDC4 |
arrestin domain containing 4 |
chr17_+_21187976 | 0.33 |
ENST00000342679.4 |
MAP2K3 |
mitogen-activated protein kinase kinase 3 |
chr11_+_65082289 | 0.33 |
ENST00000279249.2 |
CDC42EP2 |
CDC42 effector protein (Rho GTPase binding) 2 |
chrX_-_20284958 | 0.33 |
ENST00000379565.3 |
RPS6KA3 |
ribosomal protein S6 kinase, 90kDa, polypeptide 3 |
chr12_+_125478241 | 0.33 |
ENST00000341446.8 |
BRI3BP |
BRI3 binding protein |
chr12_-_12419703 | 0.33 |
ENST00000543091.1 ENST00000261349.4 |
LRP6 |
low density lipoprotein receptor-related protein 6 |
chr14_+_23775971 | 0.33 |
ENST00000250405.5 |
BCL2L2 |
BCL2-like 2 |
chr1_-_114355083 | 0.33 |
ENST00000261441.5 |
RSBN1 |
round spermatid basic protein 1 |
chr20_+_19193269 | 0.33 |
ENST00000328041.6 |
SLC24A3 |
solute carrier family 24 (sodium/potassium/calcium exchanger), member 3 |
chr14_-_77279153 | 0.32 |
ENST00000251089.2 |
ANGEL1 |
angel homolog 1 (Drosophila) |
chr22_-_37915535 | 0.32 |
ENST00000403299.1 |
CARD10 |
caspase recruitment domain family, member 10 |
chr1_+_206680879 | 0.32 |
ENST00000355294.4 ENST00000367117.3 |
RASSF5 |
Ras association (RalGDS/AF-6) domain family member 5 |
chr10_-_119134918 | 0.32 |
ENST00000334464.5 |
PDZD8 |
PDZ domain containing 8 |
chr14_+_103243813 | 0.32 |
ENST00000560371.1 ENST00000347662.4 ENST00000392745.2 ENST00000539721.1 ENST00000560463.1 |
TRAF3 |
TNF receptor-associated factor 3 |
chr3_+_126707437 | 0.31 |
ENST00000393409.2 ENST00000251772.4 |
PLXNA1 |
plexin A1 |
chr13_+_97874574 | 0.31 |
ENST00000343600.4 ENST00000345429.6 ENST00000376673.3 |
MBNL2 |
muscleblind-like splicing regulator 2 |
chr14_+_32546485 | 0.31 |
ENST00000345122.3 ENST00000432921.1 ENST00000433497.1 |
ARHGAP5 |
Rho GTPase activating protein 5 |
chr8_-_141645645 | 0.31 |
ENST00000519980.1 ENST00000220592.5 |
AGO2 |
argonaute RISC catalytic component 2 |
chr12_-_71148413 | 0.31 |
ENST00000440835.2 ENST00000549308.1 ENST00000550661.1 |
PTPRR |
protein tyrosine phosphatase, receptor type, R |
chr15_+_41221536 | 0.31 |
ENST00000249749.5 |
DLL4 |
delta-like 4 (Drosophila) |
chr3_+_10857885 | 0.31 |
ENST00000254488.2 ENST00000454147.1 |
SLC6A11 |
solute carrier family 6 (neurotransmitter transporter), member 11 |
chr4_+_184826418 | 0.30 |
ENST00000308497.4 ENST00000438269.1 |
STOX2 |
storkhead box 2 |
chr19_+_49622646 | 0.30 |
ENST00000334186.4 |
PPFIA3 |
protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 3 |
chr1_-_109940550 | 0.30 |
ENST00000256637.6 |
SORT1 |
sortilin 1 |
chr12_+_95611516 | 0.30 |
ENST00000436874.1 |
VEZT |
vezatin, adherens junctions transmembrane protein |
chrX_-_119445263 | 0.30 |
ENST00000309720.5 |
TMEM255A |
transmembrane protein 255A |
chr15_+_69706585 | 0.29 |
ENST00000559279.1 ENST00000395392.2 |
KIF23 |
kinesin family member 23 |
chr1_-_22263790 | 0.29 |
ENST00000374695.3 |
HSPG2 |
heparan sulfate proteoglycan 2 |
chr20_-_31071239 | 0.29 |
ENST00000359676.5 |
C20orf112 |
chromosome 20 open reading frame 112 |
chr1_+_203274639 | 0.28 |
ENST00000290551.4 |
BTG2 |
BTG family, member 2 |
chr8_+_87354945 | 0.28 |
ENST00000517970.1 |
WWP1 |
WW domain containing E3 ubiquitin protein ligase 1 |
chr19_-_14316980 | 0.28 |
ENST00000361434.3 ENST00000340736.6 |
LPHN1 |
latrophilin 1 |
chr6_+_73331776 | 0.28 |
ENST00000370398.1 |
KCNQ5 |
potassium voltage-gated channel, KQT-like subfamily, member 5 |
chr13_+_52158610 | 0.28 |
ENST00000298125.5 |
WDFY2 |
WD repeat and FYVE domain containing 2 |
chr6_+_50681541 | 0.28 |
ENST00000008391.3 |
TFAP2D |
transcription factor AP-2 delta (activating enhancer binding protein 2 delta) |
chr3_+_43328004 | 0.28 |
ENST00000454177.1 ENST00000429705.2 ENST00000296088.7 ENST00000437827.1 |
SNRK |
SNF related kinase |
chr4_-_111119804 | 0.28 |
ENST00000394607.3 ENST00000302274.3 |
ELOVL6 |
ELOVL fatty acid elongase 6 |
chr5_+_140201183 | 0.28 |
ENST00000529619.1 ENST00000529859.1 ENST00000378126.3 |
PCDHA5 |
protocadherin alpha 5 |
chr6_+_11094266 | 0.28 |
ENST00000416247.2 |
SMIM13 |
small integral membrane protein 13 |
chr3_-_53381539 | 0.28 |
ENST00000606822.1 ENST00000294241.6 ENST00000607628.1 |
DCP1A |
decapping mRNA 1A |
chr9_+_6328338 | 0.27 |
ENST00000344545.5 |
TPD52L3 |
tumor protein D52-like 3 |
chr13_-_30169807 | 0.27 |
ENST00000380752.5 |
SLC7A1 |
solute carrier family 7 (cationic amino acid transporter, y+ system), member 1 |
chr6_+_32121218 | 0.27 |
ENST00000414204.1 ENST00000361568.2 ENST00000395523.1 |
PPT2 |
palmitoyl-protein thioesterase 2 |
chr2_+_196521458 | 0.27 |
ENST00000409086.3 |
SLC39A10 |
solute carrier family 39 (zinc transporter), member 10 |
chr10_+_105156364 | 0.27 |
ENST00000369797.3 |
PDCD11 |
programmed cell death 11 |
chr4_-_10458982 | 0.26 |
ENST00000326756.3 |
ZNF518B |
zinc finger protein 518B |
chr10_-_120840309 | 0.26 |
ENST00000369144.3 |
EIF3A |
eukaryotic translation initiation factor 3, subunit A |
chr10_+_81107216 | 0.26 |
ENST00000394579.3 ENST00000225174.3 |
PPIF |
peptidylprolyl isomerase F |
chr14_+_24867992 | 0.26 |
ENST00000382554.3 |
NYNRIN |
NYN domain and retroviral integrase containing |
chr5_-_95297678 | 0.26 |
ENST00000237853.4 |
ELL2 |
elongation factor, RNA polymerase II, 2 |
chr22_-_42017021 | 0.26 |
ENST00000263256.6 |
DESI1 |
desumoylating isopeptidase 1 |
chr11_+_100558384 | 0.26 |
ENST00000524892.2 ENST00000298815.8 |
ARHGAP42 |
Rho GTPase activating protein 42 |
chr11_-_34379546 | 0.26 |
ENST00000435224.2 |
ABTB2 |
ankyrin repeat and BTB (POZ) domain containing 2 |
chr15_+_59730348 | 0.26 |
ENST00000288228.5 ENST00000559628.1 ENST00000557914.1 ENST00000560474.1 |
FAM81A |
family with sequence similarity 81, member A |
chr17_-_74533963 | 0.26 |
ENST00000293230.5 |
CYGB |
cytoglobin |
chr22_-_37545972 | 0.26 |
ENST00000216223.5 |
IL2RB |
interleukin 2 receptor, beta |
chr7_+_36429409 | 0.25 |
ENST00000265748.2 |
ANLN |
anillin, actin binding protein |
chr4_-_90229142 | 0.25 |
ENST00000609438.1 |
GPRIN3 |
GPRIN family member 3 |
chr17_-_29624343 | 0.25 |
ENST00000247271.4 |
OMG |
oligodendrocyte myelin glycoprotein |
chr5_-_39074479 | 0.25 |
ENST00000514735.1 ENST00000296782.5 ENST00000357387.3 |
RICTOR |
RPTOR independent companion of MTOR, complex 2 |
chr19_-_11450249 | 0.25 |
ENST00000222120.3 |
RAB3D |
RAB3D, member RAS oncogene family |
chr3_+_14989076 | 0.25 |
ENST00000413118.1 ENST00000425241.1 |
NR2C2 |
nuclear receptor subfamily 2, group C, member 2 |
chr1_-_6321035 | 0.25 |
ENST00000377893.2 |
GPR153 |
G protein-coupled receptor 153 |
chr16_+_9185450 | 0.25 |
ENST00000327827.7 |
C16orf72 |
chromosome 16 open reading frame 72 |
chr2_+_168725458 | 0.24 |
ENST00000392690.3 |
B3GALT1 |
UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 1 |
chrX_+_24483338 | 0.24 |
ENST00000379162.4 ENST00000441463.2 |
PDK3 |
pyruvate dehydrogenase kinase, isozyme 3 |
chr12_-_57030115 | 0.24 |
ENST00000379441.3 ENST00000179765.5 ENST00000551812.1 |
BAZ2A |
bromodomain adjacent to zinc finger domain, 2A |
chr12_-_113623252 | 0.24 |
ENST00000314045.7 ENST00000306014.5 |
DDX54 |
DEAD (Asp-Glu-Ala-Asp) box polypeptide 54 |
chr17_-_80056099 | 0.24 |
ENST00000306749.2 |
FASN |
fatty acid synthase |
chr3_+_10206545 | 0.23 |
ENST00000256458.4 |
IRAK2 |
interleukin-1 receptor-associated kinase 2 |
chr1_-_115212696 | 0.23 |
ENST00000393276.3 ENST00000393277.1 |
DENND2C |
DENN/MADD domain containing 2C |
chr3_+_49209023 | 0.23 |
ENST00000332780.2 |
KLHDC8B |
kelch domain containing 8B |
chr8_+_25316489 | 0.23 |
ENST00000330560.3 |
CDCA2 |
cell division cycle associated 2 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 2.2 | GO:0060066 | oviduct development(GO:0060066) |
0.3 | 1.0 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
0.3 | 1.0 | GO:0048633 | negative regulation of auditory receptor cell differentiation(GO:0045608) positive regulation of skeletal muscle tissue growth(GO:0048633) |
0.3 | 0.9 | GO:0021722 | superior olivary nucleus development(GO:0021718) superior olivary nucleus maturation(GO:0021722) |
0.3 | 0.9 | GO:1903572 | coronary vein morphogenesis(GO:0003169) regulation of protein kinase D signaling(GO:1903570) positive regulation of protein kinase D signaling(GO:1903572) |
0.3 | 0.9 | GO:0050902 | leukocyte adhesive activation(GO:0050902) |
0.3 | 1.5 | GO:0038018 | Wnt receptor catabolic process(GO:0038018) |
0.3 | 0.9 | GO:1904806 | regulation of protein oxidation(GO:1904806) positive regulation of protein oxidation(GO:1904808) |
0.3 | 1.1 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.3 | 1.3 | GO:0048880 | sensory system development(GO:0048880) |
0.3 | 0.8 | GO:0035981 | tongue muscle cell differentiation(GO:0035981) positive regulation of skeletal muscle fiber differentiation(GO:1902811) regulation of tongue muscle cell differentiation(GO:2001035) positive regulation of tongue muscle cell differentiation(GO:2001037) |
0.3 | 0.8 | GO:0021966 | cerebral cortex tangential migration using cell-cell interactions(GO:0021823) postnatal olfactory bulb interneuron migration(GO:0021827) chemorepulsion involved in postnatal olfactory bulb interneuron migration(GO:0021836) corticospinal neuron axon guidance(GO:0021966) negative regulation of granulocyte chemotaxis(GO:0071623) negative regulation of mononuclear cell migration(GO:0071676) negative regulation of neutrophil chemotaxis(GO:0090024) negative regulation of neutrophil migration(GO:1902623) |
0.2 | 0.6 | GO:0002528 | regulation of vascular permeability involved in acute inflammatory response(GO:0002528) |
0.2 | 0.2 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.2 | 0.6 | GO:2000393 | negative regulation of lamellipodium morphogenesis(GO:2000393) |
0.2 | 0.2 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.2 | 0.9 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
0.2 | 0.6 | GO:1904899 | regulation of hepatic stellate cell proliferation(GO:1904897) positive regulation of hepatic stellate cell proliferation(GO:1904899) hepatic stellate cell proliferation(GO:1990922) |
0.2 | 0.6 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.2 | 0.5 | GO:0033341 | regulation of collagen binding(GO:0033341) |
0.2 | 0.6 | GO:2000969 | positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
0.2 | 1.3 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.2 | 1.2 | GO:1990034 | calcium ion export from cell(GO:1990034) |
0.2 | 0.5 | GO:1902534 | single-organism membrane invagination(GO:1902534) |
0.1 | 2.5 | GO:0097264 | self proteolysis(GO:0097264) |
0.1 | 0.4 | GO:1900220 | semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
0.1 | 0.9 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.1 | 0.4 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
0.1 | 0.8 | GO:0060005 | vestibular reflex(GO:0060005) |
0.1 | 0.4 | GO:2000298 | regulation of Rho-dependent protein serine/threonine kinase activity(GO:2000298) |
0.1 | 1.6 | GO:0007028 | cytoplasm organization(GO:0007028) |
0.1 | 0.4 | GO:0043396 | corticotropin-releasing hormone secretion(GO:0043396) regulation of corticotropin-releasing hormone secretion(GO:0043397) regulation of G-protein coupled receptor internalization(GO:1904020) |
0.1 | 0.5 | GO:1902617 | response to fluoride(GO:1902617) |
0.1 | 1.3 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.1 | 0.3 | GO:2000053 | regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000053) |
0.1 | 0.4 | GO:1903691 | positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
0.1 | 1.5 | GO:0045176 | apical protein localization(GO:0045176) |
0.1 | 0.8 | GO:2000138 | positive regulation of cell proliferation involved in heart morphogenesis(GO:2000138) |
0.1 | 0.8 | GO:0035897 | proteolysis in other organism(GO:0035897) |
0.1 | 0.9 | GO:0046940 | nucleoside monophosphate phosphorylation(GO:0046940) |
0.1 | 0.3 | GO:1903826 | arginine transmembrane transport(GO:1903826) |
0.1 | 0.3 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) translation reinitiation(GO:0002188) |
0.1 | 0.3 | GO:2000276 | negative regulation of oxidative phosphorylation uncoupler activity(GO:2000276) |
0.1 | 0.3 | GO:1904172 | regulation of bleb assembly(GO:1904170) positive regulation of bleb assembly(GO:1904172) |
0.1 | 0.9 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.1 | 14.7 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.1 | 0.3 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.1 | 1.0 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
0.1 | 0.3 | GO:0072554 | blood vessel lumenization(GO:0072554) |
0.1 | 0.9 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.1 | 0.6 | GO:0097490 | sympathetic neuron projection extension(GO:0097490) sympathetic neuron projection guidance(GO:0097491) |
0.1 | 0.3 | GO:0000912 | assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
0.1 | 0.3 | GO:2000639 | regulation of SREBP signaling pathway(GO:2000638) negative regulation of SREBP signaling pathway(GO:2000639) |
0.1 | 0.3 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.1 | 0.2 | GO:0071504 | cellular response to heparin(GO:0071504) |
0.1 | 0.2 | GO:1904339 | superior temporal gyrus development(GO:0071109) negative regulation of dopaminergic neuron differentiation(GO:1904339) |
0.1 | 0.2 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.1 | 0.4 | GO:0086048 | membrane depolarization during bundle of His cell action potential(GO:0086048) |
0.1 | 0.8 | GO:0086027 | AV node cell action potential(GO:0086016) AV node cell to bundle of His cell signaling(GO:0086027) |
0.1 | 0.5 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.1 | 0.2 | GO:0044805 | late nucleophagy(GO:0044805) |
0.1 | 0.3 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.1 | 0.2 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
0.1 | 1.3 | GO:0071481 | cellular response to X-ray(GO:0071481) |
0.0 | 0.1 | GO:0048382 | mesendoderm development(GO:0048382) |
0.0 | 0.2 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.0 | 0.5 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
0.0 | 0.3 | GO:0030099 | myeloid cell differentiation(GO:0030099) |
0.0 | 0.1 | GO:0021526 | medial motor column neuron differentiation(GO:0021526) |
0.0 | 0.2 | GO:1901093 | regulation of protein tetramerization(GO:1901090) negative regulation of protein tetramerization(GO:1901091) regulation of protein homotetramerization(GO:1901093) negative regulation of protein homotetramerization(GO:1901094) |
0.0 | 0.1 | GO:1904693 | midbrain morphogenesis(GO:1904693) |
0.0 | 0.3 | GO:0035087 | siRNA loading onto RISC involved in RNA interference(GO:0035087) |
0.0 | 1.5 | GO:0060441 | epithelial tube branching involved in lung morphogenesis(GO:0060441) |
0.0 | 0.2 | GO:1904075 | trophectodermal cell proliferation(GO:0001834) regulation of trophectodermal cell proliferation(GO:1904073) positive regulation of trophectodermal cell proliferation(GO:1904075) |
0.0 | 0.4 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.0 | 0.3 | GO:2000490 | negative regulation of hepatic stellate cell activation(GO:2000490) |
0.0 | 0.3 | GO:0038110 | interleukin-2-mediated signaling pathway(GO:0038110) |
0.0 | 0.2 | GO:0048617 | foregut morphogenesis(GO:0007440) embryonic foregut morphogenesis(GO:0048617) |
0.0 | 0.4 | GO:1904628 | response to phorbol 13-acetate 12-myristate(GO:1904627) cellular response to phorbol 13-acetate 12-myristate(GO:1904628) |
0.0 | 0.2 | GO:0071484 | cellular response to light intensity(GO:0071484) |
0.0 | 0.1 | GO:1902024 | histidine transport(GO:0015817) L-histidine transmembrane transport(GO:0089709) L-histidine transport(GO:1902024) |
0.0 | 0.1 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.0 | 0.1 | GO:0007538 | primary sex determination(GO:0007538) |
0.0 | 0.1 | GO:2001302 | lipoxin biosynthetic process(GO:2001301) lipoxin A4 metabolic process(GO:2001302) lipoxin A4 biosynthetic process(GO:2001303) |
0.0 | 0.3 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
0.0 | 0.2 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
0.0 | 0.6 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.0 | 0.7 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
0.0 | 0.1 | GO:0098917 | retrograde trans-synaptic signaling(GO:0098917) retrograde trans-synaptic signaling by soluble gas(GO:0098923) trans-synaptic signaling by soluble gas(GO:0099543) |
0.0 | 0.2 | GO:0014038 | regulation of Schwann cell differentiation(GO:0014038) |
0.0 | 0.5 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.0 | 0.5 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.0 | 0.7 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.0 | 0.2 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.0 | 0.1 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
0.0 | 0.9 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
0.0 | 0.1 | GO:0045196 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
0.0 | 0.2 | GO:0033625 | positive regulation of integrin activation(GO:0033625) |
0.0 | 0.1 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.0 | 0.2 | GO:0097411 | hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
0.0 | 0.1 | GO:0030820 | regulation of cyclic nucleotide catabolic process(GO:0030805) regulation of cAMP catabolic process(GO:0030820) regulation of purine nucleotide catabolic process(GO:0033121) |
0.0 | 0.2 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.0 | 0.3 | GO:0046465 | dolichyl diphosphate biosynthetic process(GO:0006489) dolichyl diphosphate metabolic process(GO:0046465) |
0.0 | 0.1 | GO:0005989 | lactose metabolic process(GO:0005988) lactose biosynthetic process(GO:0005989) apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
0.0 | 0.1 | GO:0019935 | cAMP-mediated signaling(GO:0019933) cyclic-nucleotide-mediated signaling(GO:0019935) |
0.0 | 0.2 | GO:0051056 | regulation of small GTPase mediated signal transduction(GO:0051056) |
0.0 | 0.1 | GO:0060152 | peroxisome localization(GO:0060151) microtubule-based peroxisome localization(GO:0060152) |
0.0 | 0.1 | GO:0061300 | cerebellum vasculature development(GO:0061300) |
0.0 | 0.1 | GO:0061183 | thyroid-stimulating hormone-secreting cell differentiation(GO:0060129) dermatome development(GO:0061054) regulation of dermatome development(GO:0061183) renal vesicle induction(GO:0072034) |
0.0 | 0.2 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
0.0 | 0.3 | GO:0019367 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.0 | 0.5 | GO:0051639 | actin filament network formation(GO:0051639) |
0.0 | 0.2 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.0 | 0.3 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.0 | 0.2 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.0 | 0.1 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
0.0 | 0.2 | GO:0052405 | negative regulation by host of symbiont molecular function(GO:0052405) |
0.0 | 0.1 | GO:0060697 | positive regulation of phospholipid catabolic process(GO:0060697) |
0.0 | 0.1 | GO:0019085 | early viral transcription(GO:0019085) |
0.0 | 0.4 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.0 | 0.2 | GO:0006682 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
0.0 | 0.3 | GO:0098734 | macromolecule depalmitoylation(GO:0098734) |
0.0 | 0.0 | GO:1903526 | negative regulation of membrane tubulation(GO:1903526) |
0.0 | 0.4 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.0 | 0.2 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.0 | 0.0 | GO:0003285 | septum secundum development(GO:0003285) |
0.0 | 0.4 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.0 | 0.5 | GO:0038092 | nodal signaling pathway(GO:0038092) |
0.0 | 0.1 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.0 | 0.5 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.0 | 0.1 | GO:0035927 | RNA import into mitochondrion(GO:0035927) |
0.0 | 0.1 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.0 | 0.2 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
0.0 | 0.2 | GO:0002118 | aggressive behavior(GO:0002118) |
0.0 | 0.1 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.0 | 0.2 | GO:0061734 | parkin-mediated mitophagy in response to mitochondrial depolarization(GO:0061734) |
0.0 | 0.2 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.0 | 0.1 | GO:0051563 | smooth endoplasmic reticulum calcium ion homeostasis(GO:0051563) |
0.0 | 0.1 | GO:0003032 | detection of oxygen(GO:0003032) |
0.0 | 0.2 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
0.0 | 0.1 | GO:0015798 | myo-inositol transport(GO:0015798) |
0.0 | 0.1 | GO:0006428 | isoleucyl-tRNA aminoacylation(GO:0006428) |
0.0 | 0.3 | GO:0015074 | DNA integration(GO:0015074) |
0.0 | 0.1 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
0.0 | 0.1 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
0.0 | 0.2 | GO:0036089 | cleavage furrow formation(GO:0036089) |
0.0 | 0.8 | GO:2000300 | regulation of synaptic vesicle exocytosis(GO:2000300) |
0.0 | 0.1 | GO:1990167 | protein K27-linked deubiquitination(GO:1990167) protein K33-linked deubiquitination(GO:1990168) |
0.0 | 0.1 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.0 | 0.2 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
0.0 | 1.3 | GO:0051496 | positive regulation of stress fiber assembly(GO:0051496) |
0.0 | 0.2 | GO:0046541 | saliva secretion(GO:0046541) |
0.0 | 0.9 | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
0.0 | 0.1 | GO:0034970 | histone H3-R2 methylation(GO:0034970) |
0.0 | 0.1 | GO:0035407 | histone H3-T11 phosphorylation(GO:0035407) |
0.0 | 1.7 | GO:0006970 | response to osmotic stress(GO:0006970) |
0.0 | 0.3 | GO:0048755 | branching morphogenesis of a nerve(GO:0048755) |
0.0 | 0.3 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
0.0 | 0.2 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.0 | 0.4 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.0 | 0.4 | GO:1904659 | hexose transmembrane transport(GO:0035428) glucose transmembrane transport(GO:1904659) |
0.0 | 0.3 | GO:0034656 | nucleobase-containing small molecule catabolic process(GO:0034656) |
0.0 | 0.1 | GO:1903895 | negative regulation of IRE1-mediated unfolded protein response(GO:1903895) |
0.0 | 0.2 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
0.0 | 0.3 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.0 | 0.1 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.0 | 0.1 | GO:0045541 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.0 | 0.2 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.0 | 0.2 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.0 | 0.0 | GO:0060437 | lung growth(GO:0060437) |
0.0 | 0.0 | GO:1990926 | short-term synaptic potentiation(GO:1990926) |
0.0 | 1.8 | GO:0051897 | positive regulation of protein kinase B signaling(GO:0051897) |
0.0 | 0.5 | GO:0051898 | negative regulation of protein kinase B signaling(GO:0051898) |
0.0 | 0.3 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.0 | 0.1 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.0 | 0.9 | GO:2001238 | positive regulation of extrinsic apoptotic signaling pathway(GO:2001238) |
0.0 | 0.3 | GO:2000178 | negative regulation of neural precursor cell proliferation(GO:2000178) |
0.0 | 0.1 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
0.0 | 0.4 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.0 | 0.1 | GO:0009212 | dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) |
0.0 | 0.3 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.0 | 0.1 | GO:0014050 | negative regulation of glutamate secretion(GO:0014050) |
0.0 | 0.1 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) |
0.0 | 0.2 | GO:0097012 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
0.0 | 0.2 | GO:0010663 | positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
0.0 | 0.7 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
0.0 | 0.1 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.0 | 0.0 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.0 | 0.1 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
0.0 | 0.0 | GO:1904562 | phosphatidylinositol 5-phosphate metabolic process(GO:1904562) |
0.0 | 0.1 | GO:0009048 | dosage compensation by inactivation of X chromosome(GO:0009048) |
0.0 | 0.1 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.0 | 0.0 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.0 | 0.0 | GO:0043254 | regulation of protein polymerization(GO:0032271) regulation of protein complex assembly(GO:0043254) |
0.0 | 0.3 | GO:0043555 | regulation of translation in response to stress(GO:0043555) |
0.0 | 0.2 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
0.0 | 0.1 | GO:0042026 | protein refolding(GO:0042026) |
0.0 | 0.1 | GO:2000465 | regulation of glycogen (starch) synthase activity(GO:2000465) |
0.0 | 0.3 | GO:0000466 | maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000466) |
0.0 | 0.1 | GO:0050966 | detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
0.0 | 0.3 | GO:1902751 | positive regulation of cell cycle G2/M phase transition(GO:1902751) |
0.0 | 0.1 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.0 | 0.1 | GO:1901409 | positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.0 | 0.1 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 1.9 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
0.2 | 0.9 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.1 | 1.0 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.1 | 0.3 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.1 | 0.4 | GO:1990742 | microvesicle(GO:1990742) |
0.1 | 0.5 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
0.1 | 0.3 | GO:0032449 | CBM complex(GO:0032449) |
0.1 | 0.3 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.1 | 0.2 | GO:0031379 | RNA-directed RNA polymerase complex(GO:0031379) |
0.1 | 0.3 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.0 | 0.3 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
0.0 | 0.2 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.0 | 0.6 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.0 | 0.6 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.0 | 0.2 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.0 | 0.1 | GO:0016938 | kinesin I complex(GO:0016938) |
0.0 | 0.6 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.0 | 0.2 | GO:0097125 | cyclin B1-CDK1 complex(GO:0097125) |
0.0 | 0.2 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.0 | 0.3 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.0 | 0.4 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.0 | 0.2 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.0 | 0.2 | GO:0031415 | NatA complex(GO:0031415) |
0.0 | 0.8 | GO:0016580 | Sin3 complex(GO:0016580) |
0.0 | 0.5 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.0 | 0.1 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
0.0 | 0.2 | GO:0042587 | glycogen granule(GO:0042587) |
0.0 | 0.3 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.0 | 0.2 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
0.0 | 0.1 | GO:0044305 | calyx of Held(GO:0044305) |
0.0 | 0.2 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.0 | 0.2 | GO:0097413 | Lewy body(GO:0097413) |
0.0 | 0.1 | GO:0016589 | NURF complex(GO:0016589) |
0.0 | 0.1 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.0 | 0.1 | GO:0098855 | HCN channel complex(GO:0098855) |
0.0 | 2.1 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.0 | 0.1 | GO:0032279 | asymmetric synapse(GO:0032279) |
0.0 | 0.3 | GO:0031932 | TORC2 complex(GO:0031932) |
0.0 | 1.4 | GO:0005811 | lipid particle(GO:0005811) |
0.0 | 1.3 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 0.2 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.0 | 0.1 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
0.0 | 0.1 | GO:1990812 | growth cone filopodium(GO:1990812) |
0.0 | 0.6 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.0 | 0.1 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.0 | 0.1 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.0 | 0.3 | GO:0042588 | zymogen granule(GO:0042588) |
0.0 | 0.0 | GO:0071149 | TEAD-2-YAP complex(GO:0071149) |
0.0 | 0.5 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.0 | 0.1 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.0 | 0.2 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.0 | 0.1 | GO:0070938 | contractile ring(GO:0070938) |
0.0 | 2.2 | GO:0043296 | apical junction complex(GO:0043296) |
0.0 | 0.2 | GO:0031045 | dense core granule(GO:0031045) |
0.0 | 0.0 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
0.0 | 0.1 | GO:0005883 | neurofilament(GO:0005883) |
0.0 | 0.1 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.0 | 0.1 | GO:0032433 | filopodium tip(GO:0032433) |
0.0 | 2.4 | GO:0030426 | growth cone(GO:0030426) |
0.0 | 0.1 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.0 | 1.7 | GO:0032587 | ruffle membrane(GO:0032587) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 0.9 | GO:0016534 | cyclin-dependent protein kinase 5 activator activity(GO:0016534) |
0.2 | 0.9 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.2 | 1.1 | GO:0046899 | nucleoside triphosphate adenylate kinase activity(GO:0046899) |
0.2 | 0.6 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.2 | 1.4 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.2 | 0.8 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.2 | 0.9 | GO:0043183 | vascular endothelial growth factor receptor 1 binding(GO:0043183) |
0.1 | 0.4 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.1 | 0.8 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.1 | 0.4 | GO:0098770 | FBXO family protein binding(GO:0098770) |
0.1 | 1.7 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.1 | 0.8 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.1 | 0.4 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.1 | 0.3 | GO:0098808 | mRNA cap binding(GO:0098808) |
0.1 | 0.5 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.1 | 0.3 | GO:0019976 | interleukin-2 receptor activity(GO:0004911) interleukin-2 binding(GO:0019976) |
0.1 | 0.8 | GO:0043237 | laminin-1 binding(GO:0043237) Roundabout binding(GO:0048495) |
0.1 | 0.2 | GO:0047275 | glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity(GO:0047275) |
0.1 | 3.5 | GO:0005109 | frizzled binding(GO:0005109) |
0.1 | 0.2 | GO:0031177 | S-acetyltransferase activity(GO:0016418) phosphopantetheine binding(GO:0031177) |
0.1 | 0.5 | GO:0038064 | collagen receptor activity(GO:0038064) |
0.1 | 0.5 | GO:0050682 | AF-2 domain binding(GO:0050682) |
0.1 | 0.2 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.1 | 0.2 | GO:0033878 | hormone-sensitive lipase activity(GO:0033878) |
0.1 | 0.2 | GO:0003839 | gamma-glutamylcyclotransferase activity(GO:0003839) |
0.1 | 0.3 | GO:0047888 | fatty acid peroxidase activity(GO:0047888) |
0.1 | 0.3 | GO:0010465 | nerve growth factor receptor activity(GO:0010465) |
0.1 | 0.8 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.1 | 1.0 | GO:0030957 | Tat protein binding(GO:0030957) |
0.1 | 0.5 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.1 | 0.2 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.1 | 2.1 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.1 | 0.7 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.1 | 0.3 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.1 | 0.2 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
0.1 | 0.3 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.1 | 0.2 | GO:0017002 | activin-activated receptor activity(GO:0017002) |
0.1 | 0.2 | GO:0015333 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
0.1 | 0.2 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.1 | 0.3 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
0.0 | 0.1 | GO:0004119 | cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) |
0.0 | 0.2 | GO:0005280 | hydrogen:amino acid symporter activity(GO:0005280) |
0.0 | 0.2 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.0 | 0.3 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.0 | 1.0 | GO:0045028 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.0 | 0.4 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.0 | 0.1 | GO:0016165 | linoleate 13S-lipoxygenase activity(GO:0016165) hepoxilin-epoxide hydrolase activity(GO:0047977) |
0.0 | 0.2 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.0 | 0.5 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.0 | 0.7 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.0 | 0.4 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.0 | 0.2 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.0 | 0.7 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.0 | 0.4 | GO:0086007 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential(GO:0086007) |
0.0 | 0.2 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.0 | 0.1 | GO:0015180 | L-alanine transmembrane transporter activity(GO:0015180) alanine transmembrane transporter activity(GO:0022858) |
0.0 | 0.3 | GO:0009922 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.0 | 0.2 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.0 | 0.2 | GO:0047493 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
0.0 | 0.1 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.0 | 1.0 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.0 | 0.2 | GO:0005052 | peroxisome matrix targeting signal-1 binding(GO:0005052) |
0.0 | 0.1 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.0 | 0.3 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.0 | 0.5 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.0 | 0.8 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.0 | 0.8 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.0 | 1.2 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.0 | 0.4 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.0 | 0.1 | GO:0004359 | glutaminase activity(GO:0004359) |
0.0 | 0.7 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.0 | 0.2 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.0 | 0.2 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.0 | 0.1 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.0 | 0.5 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.0 | 0.2 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.0 | 0.9 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
0.0 | 0.3 | GO:0031996 | thioesterase binding(GO:0031996) |
0.0 | 0.1 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
0.0 | 0.1 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) axon guidance receptor activity(GO:0008046) |
0.0 | 0.1 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
0.0 | 0.1 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.0 | 0.1 | GO:0004822 | isoleucine-tRNA ligase activity(GO:0004822) |
0.0 | 0.3 | GO:0051400 | BH domain binding(GO:0051400) |
0.0 | 0.1 | GO:0043426 | MRF binding(GO:0043426) |
0.0 | 0.3 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.0 | 0.2 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.0 | 0.1 | GO:0034041 | sterol-transporting ATPase activity(GO:0034041) |
0.0 | 0.1 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.0 | 0.2 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.0 | 0.3 | GO:0016462 | pyrophosphatase activity(GO:0016462) |
0.0 | 0.0 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.0 | 0.7 | GO:0003785 | actin monomer binding(GO:0003785) |
0.0 | 0.1 | GO:0070905 | serine binding(GO:0070905) |
0.0 | 0.6 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.0 | 0.2 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.0 | 0.2 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.0 | 0.0 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.0 | 15.6 | GO:0005509 | calcium ion binding(GO:0005509) |
0.0 | 0.2 | GO:0001164 | RNA polymerase I regulatory region DNA binding(GO:0001013) RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
0.0 | 0.1 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.0 | 0.2 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.0 | 0.4 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.0 | 1.0 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.0 | 0.1 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
0.0 | 0.1 | GO:0044715 | 8-oxo-dGDP phosphatase activity(GO:0044715) |
0.0 | 0.1 | GO:0047179 | platelet-activating factor acetyltransferase activity(GO:0047179) |
0.0 | 1.3 | GO:0032947 | protein complex scaffold(GO:0032947) |
0.0 | 0.0 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.0 | 0.3 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.0 | 0.4 | GO:0031489 | myosin V binding(GO:0031489) |
0.0 | 3.7 | GO:0003729 | mRNA binding(GO:0003729) poly(A) RNA binding(GO:0044822) |
0.0 | 0.1 | GO:0035402 | histone kinase activity (H3-T11 specific)(GO:0035402) |
0.0 | 0.2 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
0.0 | 0.2 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.0 | 0.6 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.0 | 0.1 | GO:0089720 | caspase binding(GO:0089720) |
0.0 | 0.2 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.0 | 0.1 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.0 | 0.0 | GO:0070644 | vitamin D response element binding(GO:0070644) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.3 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.1 | 1.5 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.1 | 0.8 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.1 | 0.1 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.1 | 2.1 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.1 | 0.8 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.0 | 0.2 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.0 | 0.5 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.0 | 1.6 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.0 | 1.1 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.0 | 1.7 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.0 | 1.2 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.0 | 1.0 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.0 | 0.6 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.0 | 0.9 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.0 | 1.0 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.0 | 1.1 | PID ARF6 PATHWAY | Arf6 signaling events |
0.0 | 0.4 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.0 | 0.7 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.0 | 0.2 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.0 | 0.9 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.0 | 0.5 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.0 | 1.0 | PID NOTCH PATHWAY | Notch signaling pathway |
0.0 | 0.5 | PID ALK1 PATHWAY | ALK1 signaling events |
0.0 | 0.2 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.0 | 0.2 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 1.5 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.1 | 1.2 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.1 | 2.2 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.1 | 0.7 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.1 | 2.2 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.1 | 0.9 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
0.0 | 1.0 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.0 | 1.5 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.0 | 0.5 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.0 | 0.9 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.0 | 0.4 | REACTOME RAF MAP KINASE CASCADE | Genes involved in RAF/MAP kinase cascade |
0.0 | 0.9 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.0 | 2.1 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.0 | 0.7 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.0 | 0.5 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.0 | 1.0 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.0 | 0.4 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.0 | 0.6 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.0 | 0.2 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.0 | 1.0 | REACTOME CELL CELL JUNCTION ORGANIZATION | Genes involved in Cell-cell junction organization |
0.0 | 0.7 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.0 | 1.4 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.0 | 0.2 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.0 | 0.6 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.0 | 0.3 | REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
0.0 | 2.3 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 0.1 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
0.0 | 0.3 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.0 | 0.5 | REACTOME FATTY ACYL COA BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
0.0 | 0.3 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.0 | 0.3 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.0 | 0.6 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.0 | 0.3 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.0 | 0.3 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.0 | 0.2 | REACTOME INCRETIN SYNTHESIS SECRETION AND INACTIVATION | Genes involved in Incretin Synthesis, Secretion, and Inactivation |
0.0 | 0.8 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.0 | 0.3 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.0 | 0.3 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |